Related references
Note: Only part of the references are listed.Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma
XiaoLi Liu et al.
PHYTOMEDICINE (2019)
The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis
Jingjing Liu et al.
BIOSCIENCE REPORTS (2019)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
Chendong Yang et al.
ONCOTARGETS AND THERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
Sheng-Yan Xi et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer
Lee S. Schwartzberg et al.
JOURNAL OF CANCER (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients
Yueh-Hsiang Liao et al.
LIVER INTERNATIONAL (2015)
The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer
Fanghua Qi et al.
BIOSCIENCE TRENDS (2015)
Effect of Cantharidins in Chemotherapy for Hepatoma: A Retrospective Cohort Study
Wei Zhang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2014)
Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation-induced tumor growth
Xinli Huang et al.
MOLECULAR MEDICINE REPORTS (2014)
Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice
Bin Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
In vitro and in vivo hepatoprotective and antioxidant effects of Astragalus polysaccharides against carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio)
Rui Jia et al.
FISH PHYSIOLOGY AND BIOCHEMISTRY (2012)
Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes
Yun Lu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy receiving chemotherapy
Hiroshi Higashiyama et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma
M Ozguroglu et al.
MEDICAL ONCOLOGY (2004)